Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00086801

Public ClinicalTrials.gov record NCT00086801. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 7:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Doxorubicin, Vinblastine, and Gemcitabine (AVG) Chemotherapy for Non-Bulky Stage I and II Hodgkin's Lymphoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as doxorubicin, vinblastine, and gemcitabine, work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating patients with newly diagnosed stage I or stage II Hodgkin's lymphoma.

Study identification

NCT ID
NCT00086801
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
104 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Mar 2007 (Actual)
Completion
May 2011 (Actual)
Last update posted
Jul 1, 2016

2004 – 2011

United States locations

U.S. sites
47
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
UCSF Comprehensive Cancer Center San Francisco California 94115 —
Beebe Medical Center Lewes Delaware 19958 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5001 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Elkhart General Hospital Elkhart Indiana 46515 —
Howard Community Hospital at Howard Regional Health System Kokomo Indiana 46904 —
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Memorial Hospital of South Bend South Bend Indiana 46601 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
Iowa Blood and Cancer Care Cedar Rapids Iowa 52402 —
St. Luke's Hospital Cedar Rapids Iowa 52402 —
Mercy Regional Cancer Center at Mercy Medical Center Cedar Rapids Iowa 52403 —
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland 21201 —
Union Hospital Cancer Center at Union Hospital Elkton MD Maryland 21921 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
Dana-Farber/Brigham and Women's Cancer Center Brigham and Women's Hospital Boston Massachusetts 02115 —
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts 02115 —
Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph Saint Joseph Michigan 49085 —
University of Minnesota Medical Center - Fairview Minneapolis Minnesota 55455 —
Missouri Cancer Associates Columbia Missouri 65201 —
Siteman Cancer Center at Barnes-Jewish Hospital St Louis Missouri 63110 —
Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center Grand Island Nebraska 68803 —
Great Plains Regional Medical Center North Platte Nebraska 69101-6598 —
UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska 68198-6805 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Charles R. Wood Cancer Center at Glens Falls Hospital Glens Falls New York 12801 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
New York Weill Cornell Cancer Center at Cornell University New York New York 10021 —
CCOP - Hematology-Oncology Associates of Central New York Syracuse New York 13057 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
Community General Hospital Syracuse New York 13215 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina 28233-3549 —
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534 —
Wayne Radiation Oncology Goldsboro North Carolina 27534 —
Lenoir Memorial Cancer Center Kinston North Carolina 28501 —
Wilson Medical Center Wilson North Carolina 27893-3428 —
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus Ohio 43210-1240 —
Bon Secours St. Francis Health System Greenville South Carolina 29601 —
CCOP - Greenville Greenville South Carolina 29615 —
Mountainview Medical Berlin Corners Vermont 05602 —
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00086801, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2016 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00086801 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →